APP and Alzheimer disease: Consequently, the ISR would be re-elicited, the operation of the AβPP-independent C100/C99 generation pathway restored, and the accumulation of iAβ and progression of AD would resume at the pre-treatment rate; the benefits of the treatment would be limited to the duration of its administration.